Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somaticChristof Winter, Lao H. Saal, Niklas Loman et al.|Annals of Oncology|2016Cited by 152
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancerMartin Nilsson, Niklas Loman, Linda Hartman et al.|Breast Cancer Research and Treatment|2014Cited by 56
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation statusMartin Nilsson, Niklas Loman, Linda Hartman et al.|Breast Cancer Research and Treatment|2014Cited by 29
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancerMartin Nilsson, Niklas Loman, Christof Winter et al.|Familial Cancer|2017Cited by 22
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancerMartin Nilsson, Niklas Loman, Therese Törngren et al.|Breast Cancer Research and Treatment|2017Cited by 20